クモ膜下の英語

頭蓋内出血手術、特にクモ膜下出血手術後におこる脳血管攣縮に関して有効な予防薬及び／又は治療薬を提供する。例文帳に追加

To provide a medicament for prophylaxis and/or therapy which has an effect upon cerebrovascular spasm taking place after an operation for intracranial hemorrhage, especially after an operation for subarachnoidal hemorrhage. - 特許庁

手術部位へアクセスするための改善された装置および方法、特に、静脈、動脈、硬膜上腔、胸腔、クモ膜下腔、心室、脊髄腔、および滑膜腔などの腹部から小血管に至る様々な大きさの解剖学的内腔などの手術部位に皮膚を介してアクセスするための、様々な器具に用いることができる可撓性アクセスポートを提供する。例文帳に追加

To provide improved methods and devices for providing access to a surgical site, and to provide a flexing access port to be used for various instruments for providing access through skin to the surgical site, such as anatomical cavities ranging in size from the abdomen to small blood vessels, such as veins and arteries, epidural, pleural and subarachnoid spaces, heart ventricles, as well as spinal and synovial cavities. - 特許庁

その結果、従来の脳血管障害の危険因子に加え、アテローム血栓性脳梗塞では８個の遺伝子多型、脳出血では９個の遺伝子多型、クモ膜下出血では１０個の遺伝子多型を加えたリスク検出法は、脳血管障害の一次、二次予防に有用であることが示された。例文帳に追加

As a result of the investigation, it has been clarified that the risk detection based on 8 genetic polymorphisms for atherothrombotic cerebral infarction, 9 genetic polymorphisms for cerebral hemorrhage and 10 genetic polymorphisms for subarachnoid hemorrhage in addition to the conventional risk factors for cerebrovascular disorder is useful for the primary and secondary prevention of cerebrovascular disorder. - 特許庁

１１４１人の脳血管障害患者（アテローム血栓性脳梗塞患者６３６人、脳出血患者２８２人、クモ膜下出血患者２２３人）とコントロール者２０１０人とについて、１５２個の候補遺伝子に関し２０２個の遺伝子多型を測定し、上記３疾患の発症に有意に関連する遺伝子多型を検出した。例文帳に追加

Two hundred and two genetic polymorphisms relating to 152 candidate genes were measured on 1,141 patients of cerebrovascular disorder (636 patients of atherothrombotic cerebral infarction, 282 patients of cerebral hemorrhage and 223 patients of subarachnoid hemorrhage) and 2,010 controls to detect genetic polymorphisms significantly relating to the onset of these 3 diseases. - 特許庁